170
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses

, , , , , , & show all
Pages 263-273 | Received 11 Jul 2015, Accepted 17 Mar 2016, Published online: 07 Apr 2016

References

  • Absolom DR, Zingg W, Neumann AW. Protein adsorption to polymer particles: Role of surface properties. J Biomed Mater Res, 1987;21:161–71.
  • Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev, 2009;61:428–37.
  • Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev, 2007;59:478–90.
  • Barman RK, Iwao Y, Funakoshi Y, Ranneh AH, Noguchi S, Wahed MI, Itai S. Development of highly stable nifedipine solid lipid nanoparticles. Chem Pharm Bull, 2014;62:399–406. (Tokyo).
  • Bhargava A, Mishra D, Khan S, Varshney SK, Banerjee S, Mishra PK. Assessment of tumor antigen-loaded solid lipid nanoparticles as an efficient delivery system for dendritic cell engineering. Nanomedicine (Lond), 2013;8:1067–84.
  • Bomford R. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, Alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol, 1980;39:435–41.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976;72:248–54.
  • Bramwell VW, Eyles JE, Somavarapu S, Alpar HO. Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology, 2002;106:412–18.
  • Brewer JM, Pollock KG, Tetley L, Russell DG. Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles. J Immunol, 2004;173:6143–50.
  • Brown KT. Fatal pulmonary complications after arterial embolization with 40-120-μm tris-acryl gelatin microspheres. J Vasc Interv Radiol, 2004;15:197–200.
  • Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett, 2006;6:662–8.
  • Chiu TH, Nyilas E, Lederman DM. Thermodynamics of native protein/foreign surface interactions. IV. Calorimetric and microelectrophoretic study of human fibrinogen sorption onto glass and LTI carbon. Trans Am Soc Artif Intern Organs, 1976;22:498–513.
  • Congdon KL, Gedeon PC, Suryadevara CM, Caruso HG, Cooper LJ, Heimberger AB, Sampson JH. Epidermal growth factor receptor and variant III targeted immunotherapy. Neuro Oncol, 2014; 8:viii20–5.
  • Conway BR, Eyles JE, Alpar HO. A comparative study on the immune response to antigen in PLA and PHB microspheres. J Control Release, 1997;49:1–9.
  • Dillon SB, Demuth SG, Schneider MA, Weston CB, Jones CS, Young JF, Scott M, Bhatnaghar PK, LoCastro S, Hanna N. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine, 1992;10:309–18.
  • Dixit N, Vaibhav K, Pandey RS, Jain UK, Katare OP, Katyal A, Madan J. Improved cisplatin delivery in cervical cancer cells by utilizing folate grafted non-aggregated gelatin nanoparticles. Biomed Pharmacother, 2015;69:1–10.
  • Dorner T, Kinnman N, Tak PP. Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers. Pharmacol Ther, 2010;125:464–75.
  • Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM. Biodegradable microspheres as a vaccine delivery system. Mol Immunol, 1991;28:287–94.
  • Erni C, Suard C, Freitas S, Dreher D, Merkle HP, Walter E. Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials, 2002;23:4667–76.
  • Fan T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. Eur J Pharm Biopharm, 2014;88:518–28.
  • Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz GA, Li J, Mottram PL, McKenzie IF, Plebanski M. Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors. J Immunol, 2004;173:3148–54.
  • Filion MC, Phillips NC. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta, 1997;1329:345–56.
  • Flach TL, Ng G, Hari A, Desrosiers MD, Zhang P, Ward SM, Seamone ME, Vilaysane A, Mucsi AD, Fong Y, et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med, 2011;17:479–87.
  • Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm, 2005;298:315–22.
  • Gebril AM, Lamprou DA, Alsaadi MM, Stimson WH, Mullen AB, Ferro VA. Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles. Nanomedicine, 2014;10:971–9.
  • Goto N, Kato H, Maeyama J, Shibano M, Saito T, Yamaguchi J, Yoshihara S. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties. Vaccine, 1997;15:1364–71.
  • Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA, 2008;105:11613–18.
  • Guo H, Qian H, Sun S, Sun D, Yin H, Cai X, Liu Z, Wu J, Jiang T, Liu X. Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye. Chem Cent J, 2011;5:1
  • Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces, 2005;45:167–73.
  • Jeong YI, Shim YH, Kim C, Lim GT, Choi KC, Yoon C. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(dl-lactide-co-glycolide). J Microencapsul, 2005;22:593–601.
  • Jordan MB, Mills DM, Kappler J, Marrack P, Cambier JC. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science, 2004;304:1808–10.
  • Jung T, Kamm W, Breitenbach A, Klebe G, Kissel T. Loading of tetanus toxoid to biodegradable nanoparticles from branched poly (sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: A mechanistic study. Pharm Res, 2002a;19:1105–13.
  • Jung T, Koneberg R, Hungerer KD, Kissel T. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: Immune response in mice . Int J Pharm, 2002b;234:75–90.
  • Kanchan V, Panda AK. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials, 2007;28:5344–57.
  • Knudsen KB, Northeved H, Kumar PE, Permin A, Gjetting T, Andresen TL, Larsen S, Wegener KM, Lykkesfeldt J, Jantzen K, et al. In vivo toxicity of cationic micelles and liposomes. Nanomedicine, 2015;11:467–77.
  • Kusonwiriyawong C, Lipipun V, Vardhanabhuti N, Zhang Q, Ritthidej GC. Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: Physico-chemical properties and cellular uptake by dendritic cells and macrophages. Pharm Res, 2013;30:1677–97.
  • Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int, 2014; 2014:180549.
  • Lue C, van den Wall Bake AW, Prince SJ, Julian BA, Tseng ML, Radl J, Elson CO, Mestecky J. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol, 1994;96:356–63.
  • Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2012;64:83–101.
  • Mishra H, Mishra D, Mishra PK, Nahar M, Dubey V, Jain NK. Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route. J Pharm Pharm Sci, 2010;13:495–509.
  • Mohan T, Verma P, Rao DN. Novel adjuvants & delivery vehicles for vaccines development: A road ahead. Indian J Med Res, 2013;138:779–95.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 1983;65:55–63.
  • Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art . Eur J Pharm Biopharm, 2000;50:161–77.
  • Nyilas E, Chiu TH, Herzlinger GA. Thermodynamics of native protein/foreign surface interactions. I. Calorimetry of the human gamma-globulin/glass system. Trans Am Soc Artif in-tern Organs, 1974;20:480–90.
  • Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomed, 2014;9:51–63.
  • Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: Correlating particle sizes and the resultant immune responses. Expert Rev Vaccines, 2010;9:1095–107.
  • Plotkin S, Orenstein W, Offit P. 2012. Vaccines, 6th edn. San Diego, CA: Saunders Elsevier, pp. 1576.
  • Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: From concepts to clinic. Crit Rev Ther Drug Carrier Syst, 2009;26:523–80.
  • Pyrgiotakis G, Blattmann CO, Pratsinis S, Demokritou P. Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir, 2013;29:11385–95.
  • Qiu Y, Liu Y, Wang L, Xu L, Bai R, Ji Y, Wu X, Zhao Y, Li Y, Chen C. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials, 2010;31:7606–19.
  • Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. J Microencapsul, 2001;18:723–32.
  • Ramanathan VD, Badenoch-Jones P, Turk JL. Complement activation by aluminium and zirconium compounds. Immunology, 1979;37:881–8.
  • Raychaudhuri S, Rock KL. Fully mobilizing host defense: Building better vaccines. Nat Biotechnol, 1998;16:1025–31.
  • Rizwan SB, McBurney WT, Young K, Hanley T, Boyd BJ, Rades T, Hook S. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses. J Control Release, 2013;165:16–21.
  • Ryabchikova EI, Mazurkova NA, Shikina NV, Ismagilov ZR. The crystalline forms of titanium dioxide nanoparticles affect their interactions with individual cells. J Med CBR Def, 2010;8. Available at: http://www.jmedcbr.org/issue_0801/Ryabchikova/Ryabchikova_Nano_10_2010.html.
  • Saini J, Bansal V, Chandra A, Madan J, Jain UK, Chandra R, Jain SM. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells. Colloids Surf B Biointerfaces, 2014;118:101–10.
  • Smith RH, Ziola B. Cyclophosphamide and dimethyl dioctadecyl ammonium bromide immunopotentiate the delayed-type hypersensitivity response to inactivated enveloped viruses. Immunol, 1986;58:245–50.
  • Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification diffusion technique. Int J Pharm, 2003;257:153–60.
  • Wang G, Pan L, Zhang Y, Wang Y, Zhang Z, Lu J, Zhou P, Fang Y, Jiang S. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge. PLoS One, 2011;6:e27605
  • Wang JH, Bartlett JD, Dunn AC, Small S, Willis SL, Driver MJ, Lewis AL. The use of rhodamine 6G and fluorescence microscopy in the evaluation of phospholipid-based polymeric biomaterials. J Microsc, 2005;217:216–24.
  • Wang Z, Zhu K, Bai W, Jia B, Hu H, Zhou D, Zhang X, Zhang X, Xie Y, Bourgine MM, et al. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection. J Virol, 2014;88:3004–15.
  • Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski M. Pathogen recognition and development of particulate vaccines: Does size matter? Methods, 2006;40:1–9.
  • Yang Y, Corona A, 3rd, Henson MA. Experimental investigation and population balance equation modeling of solid lipid nanoparticle aggregation dynamics. J Colloid Interface Sci, 2012;374:297–307.
  • Yuan F, Chen J, Sun PP, Guan S, Xu J. Wedelolactone inhibits LPS-induced pro-inflammation via NF-kappaB pathway in RAW 264.7 cells. J Biomed Sci, 2013;20:84–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.